Almost every Senate Republican on Thursday urged the Food and Drug Administration (FDA) to “reevaluate” whether a newly approved generic version of the abortion drug mifepristone should stay on the market.

The letter to Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary from 51 of 53 Republicans adds to the pressure the Trump administration is facing from conservatives to restrict access to medication abortion.

Sens. Susan Collins (R-Maine) and Lisa Murkowski (R-Alaska) were the only two Republicans who did not sign the letter.

The senators commended the agency’s recent commitment to conduct a safety review of mifepristone, one of two drugs taken for a medication abortion.

But they questioned why the agencies would approve another generic versio

See Full Page